Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit.
The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured.
Labs Launching Employer SARS-CoV-2 Testing Programs as Businesses Reopen
Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.
Genetic Technologies, TGen to Launch Genetic Tests in US
The partners will work together on a US commercialization strategy for Genetic Technologies' line of existing and future polygenic risk tests.